COGNICURRENT

The article discusses the effectiveness of the tick-borne encephalitis vaccine, with a pharmacist stating it can be up to 98% effective but does not guarantee immunity against the disease if bitten by an infected tick.

Argentina's Ministry of Health has advanced the schedule for the second dose of the triple viral vaccine to be administered between 15 and 18 months of age.

The Argentine government has advanced the schedule for administering the second dose of the triple viral vaccine to children aged 15 to 18 months, effective from July 2024.

A new Swedish study shows that the HPV vaccine reduces the risk of cervical cancer for at least 18 years, with those vaccinated before age 17 experiencing nearly an 80% lower risk than unvaccinated women.

More than a dozen states have filed a lawsuit against the Trump administration concerning newly revised vaccine recommendations for children, arguing that the changes pose a public health threat.

The Brazilian state of Amapá has received 500 doses of a vaccine designed to prevent severe forms of bronchiolitis in infants caused by the respiratory syncytial virus.

Researchers at Stanford Medicine have developed a nasal spray vaccine that offers potential protection against COVID-19, influenza, and pneumonia.

A new study reveals the mechanisms behind rare but serious complications following adenovirus-based Covid-19 vaccinations, known as vaccine-induced immune thrombotic thrombocytopenia (VITT).

Fifteen U.S. states have filed a lawsuit against the Trump administration's new vaccine policy, which limits vaccination recommendations for children at risk of certain diseases.

Argentina is advancing its influenza vaccination campaign in response to a newly identified and more contagious strain of the virus.

The U.S. Coast Guard has reinstated 56 members dismissed for refusing the COVID vaccine, citing a significant step for personal freedoms.

A coalition of 14 states is suing the Trump administration over newly implemented changes in the vaccine policy regarding several diseases, including COVID-19.

Sergipe has received 7,900 doses of a dengue vaccine produced by the Butantan Institute, aimed initially at health professionals.

Rio de Janeiro has started administering a new dengue vaccine, developed by the Butantan Institute, exclusively to frontline healthcare workers.

The WA government has introduced a $140 million plan to enhance healthcare capacity and vaccine initiatives to prevent a recurrence of last year's severe flu season.

Minas Gerais has begun administering a new chikungunya vaccine developed by Instituto Butantan, designed for adults aged 18 to 59 without immune deficiencies.

Alagoas has begun administering the nirsevimab vaccine to newborns to provide immediate protection against respiratory syncytial virus (RSV), a leading cause of bronchiolitis in young children.

The São Paulo government has expedited the delivery of 1.3 million doses of the dengue vaccine from the Butantan Institute to the Ministry of Health, as announced by Governor Tarcísio de Freitas.

Concerns arise about a possible resurgence of polio in the US as a top vaccine adviser indicates that existing vaccine recommendations could be reevaluated, prompting worries among experts and survivors about the preparedness of healthcare systems to handle a polio outbreak.

The São Paulo government has announced the delivery of an additional 1.3 million doses of the dengue vaccine and the establishment of a new hub for immunobiologicals.

Scientists are making significant progress towards a universal vaccine that could protect against colds, flu, COVID-19, and even allergies.

A recent study suggests that a new nasal spray could serve as a protective tool against viruses and bacteria, potentially becoming essential in the fight against future pandemics.

A new universal vaccine developed by a group of US scientists protects vaccinated mice from various respiratory infections.

An audit has revealed that South Korea's Disease Control Agency failed to take action after receiving reports of harmful substances in COVID-19 vaccines, leading to the administration of 14.2 million doses.

The arrival of Foot-and-Mouth Disease vaccines in South Africa is seen as a crucial development for the country's agricultural sector, enhancing economic growth and job creation.

On February 23, 1954, the first polio vaccine was administered to school children in Pittsburgh, marking a significant turning point in the fight against polio.

Research shows that the shingles vaccine may reduce the risk of dementia, but uncertainty remains about its efficacy in safeguarding memory.

Researchers from Stanford Medicine and collaborating institutions are testing a new approach to vaccines that could lead to the development of a universal vaccine.

Australia is grappling with vaccine hesitancy, influenced by persistent myths, particularly the discredited link between vaccines and autism.

A study led by researcher Mia-Marie Hammarlin reveals that vaccine skeptics often prioritize concerns over side effects over the fear of illness itself.

The first batch of the dengue vaccine has arrived in Piauí, Brazil, to immunize around 32,200 healthcare workers.

A Nigerian pediatrician emphasizes the importance of parents reporting vaccine reactions in children to improve immunization programs.

Guinea-Bissau has canceled a US-funded hepatitis B vaccine study after the World Health Organization expressed ethical concerns about its design.

US scientists have developed a universal vaccine that could provide long-term immunity against coughs, colds, flu, and even some allergens.

A Czech scientist asserts that the DNA vaccine will not bring about significant changes.

BioNTech has sued Moderna in a Delaware federal court, claiming that Moderna's mNEXSPIKE vaccine violates BioNTech and Pfizer's patent for their Comirnaty vaccine.

The CDC's vaccine advisory panel meeting has been postponed due to legal challenges regarding its validity and pressure from Robert F. Kennedy Jr. to alter vaccination policies.

Over 1.3 million children in southern Malawi are being vaccinated against polio in response to a recent outbreak linked to a detected vaccine-derived virus.

Experts raise concerns that Jay Bhattacharya, newly appointed acting head of the CDC and a vaccine skeptic, may influence vaccine policy in line with Robert F. Kennedy Jr.'s agenda.

Moderna has announced that the FDA has reversed its decision and will analyze its new flu vaccine, which uses mRNA technology.

Scientists have developed a universal vaccine that shows promise for protection against multiple respiratory infections and allergies, based on research conducted in mice.

A recent study published in the journal 'Vaccine' shows that booster vaccinations significantly decreased the incidence of severe COVID-19 outcomes, with similar efficacy found for Moderna and Pfizer/BioNTech boosters, though protection waned over time.

Western Australians aged 65 and older living in residential aged care will receive free RSV vaccinations following a severe flu season, with the program expected to significantly improve health outcomes for vulnerable populations.

Big pharmaceutical companies like Moderna are increasing investment in Mexico due to a measles outbreak that has claimed 31 lives and exceeded 10,000 cases.

An experimental mRNA vaccine shows promising outcomes in a small trial for triple-negative breast cancer patients.

The FDA has decided to review Moderna's application for its mRNA-based flu vaccine after initially declining it, responding to criticism regarding its decision-making processes.

The FDA initially rejected Moderna's application for a new flu vaccine but has since agreed to review it based on new regulatory pathways for older adults following a constructive meeting.

A clinical trial shows promising results for a personalized vaccine targeting triple-negative breast cancer, with hopes for approval within four years.

South Africa is set to receive one million vaccine doses to combat a severe outbreak of foot-and-mouth disease affecting its livestock sector.

Finland's influenza season is now in its eighth week with no end in sight, as health experts report that mutated strains are diminishing vaccine effectiveness.